Trial intelligence / Profile preview

Terlipressin in the treatment of catecholamine-resistant septic shock

2007-000513-12Phase 4Completed

Sponsor
Úrazová nemocnice Brno
Start
Feb 2007
Modality
Peptides
Countries
1
01

Overview

Phase 4 trial of terlipressin in septic shock (2 arms), sponsored by Úrazová nemocnice Brno. Primary endpoint: Hemodynamic parameters. Started Feb 2007; status: completed.

02

Drugs

terlipressin
03

Conditions

septic shock

Beyond the preview

Go deeper on 2007-000513-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000513-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call